Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Changes in weight loss, body composition and cardiovascular disease risk after altering macronutrient distributions during a regular exercise program in obese women.
Kerksick CM, Wismann-Bunn J, Fogt D, Thomas AR, Taylor L, Campbell BI, Wilborn CD, Harvey T, Roberts MD, La Bounty P, Galbreath M, Marcello B, Rasmussen CJ, Kreider RB. Kerksick CM, et al. Among authors: galbreath m. Nutr J. 2010 Nov 22;9:59. doi: 10.1186/1475-2891-9-59. Nutr J. 2010. PMID: 21092228 Free PMC article. Clinical Trial.
Effects of Adherence to a Higher Protein Diet on Weight Loss, Markers of Health, and Functional Capacity in Older Women Participating in a Resistance-Based Exercise Program.
Galbreath M, Campbell B, LaBounty P, Bunn J, Dove J, Harvey T, Hudson G, Gutierrez JL, Levers K, Galvan E, Jagim A, Greenwood L, Cooke MB, Greenwood M, Rasmussen C, Kreider RB. Galbreath M, et al. Nutrients. 2018 Aug 11;10(8):1070. doi: 10.3390/nu10081070. Nutrients. 2018. PMID: 30103509 Free PMC article. Clinical Trial.
A carbohydrate-restricted diet during resistance training promotes more favorable changes in body composition and markers of health in obese women with and without insulin resistance.
Kreider RB, Rasmussen C, Kerksick CM, Wilborn C, Taylor L 4th, Campbell B, Magrans-Courtney T, Fogt D, Ferreira M, Li R, Galbreath M, Iosia M, Cooke M, Serra M, Gutierrez J, Byrd M, Kresta JY, Simbo S, Oliver J, Greenwood M. Kreider RB, et al. Among authors: galbreath m. Phys Sportsmed. 2011 May;39(2):27-40. doi: 10.3810/psm.2011.05.1893. Phys Sportsmed. 2011. PMID: 21673483 Clinical Trial.
Aryl morpholino triazenes inhibit cytochrome P450 1A1 and 1B1.
Lee D, Perez P, Jackson W, Chin T, Galbreath M, Fronczek FR, Isovitsch R, Iimoto DS. Lee D, et al. Among authors: galbreath m. Bioorg Med Chem Lett. 2016 Jul 15;26(14):3243-3247. doi: 10.1016/j.bmcl.2016.05.064. Epub 2016 May 24. Bioorg Med Chem Lett. 2016. PMID: 27265259
20 results